Adoption of practice guidelines and assessment tools in substance abuse treatment

Substance Abuse: Treatment, Prevention, and Policy

Volumn 5, Issue 1, 2010, Pages

  Rieckmann, Traci ^a   Fuller, Bret E ^b   Saedi, Goal A ^c   McCarty, Dennis ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; HEALTH CARE SURVEY; HUMAN; MASS COMMUNICATION; PRACTICE GUIDELINE; THEORETICAL MODEL; UNITED STATES;

DIFFUSION OF INNOVATION; HEALTH CARE SURVEYS; HUMANS; MODELS, THEORETICAL; NEW ENGLAND; PRACTICE GUIDELINES AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 77950847454     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/1747-597X-5-4     Document Type: Article

References (38)

1. Brown B, Flynn P. The federal role in drug abuse technology transfer: A history and perspective. J Subst Abuse Treat 2002, 22:245-257. 10.1016/S0740-5472(02)00228-3, 12072168.
2. McCarty D, Goldman HH. Treatment for alcohol and drug dependence: History, workforce, organization, financing, and emerging policies. Substance Abuse: A Comprehensive Textbook 2003, 1346-1360. Philadelphia, Lippincott, Williams & Wilkins, Lowinson JH, Ruiz P, Millman RR, Langrod JG, 4.
3. Field M, Lohr K. Guidelines for Clinical Practice: From Development to Use 1992, Washington, DC, National Academy Press.
4. Nathan P. Practice guidelines not yet ideal. American Psychologist 1998, 53:290-299.
5. Weisz G, Cambrosio A, Keating P, Knaapen L, Schlich T, Tournay VJ. The emergence of clinical practice guidelines. Milbank Q 2007, 85:691-727.
6. Fiellin DA, Barthwell AG. Guideline development for office-based pharmacotherapies for opioid dependence. J Addict Dis 2003, 22:109-120. 10.1300/J069v22n04_09, 14723481.
7. Walker RD, Howard MO, Walker PS, Lambert MD, Suchinsky RT. Practice guidelines in the addictions. West J Med 1994, 161:39-44. 1011365, 7941505.
8. American Psychiatric Association Steering Committee on Practice Guidelines Practice guideline for the treatment of patients with substance use disorders. 2006, 2, American Psychiatric Association Steering Committee on Practice Guidelines., http://www.psychiatryonline.com/pracGuide/pracGuideChapToc_5.aspx
9. Hoffmann N, Halikas J, Mee Lee D, Weedman RD. Patient Placement Criteria for the Treatment of Psychoactive Substance Use Disorders 1991, Washington, DC, American Society of Addiction Medicine.
10. American Society of Addiction Medicine ASAM PPC-2R: ASAM Patient Placement Criteria for the Treatment of Substance Abuse-Related Disorders 2001, Chevy Chase, MD, American Society of Addiction Medicine, American Society of Addiction Medicine.
11. American Psychological Association Criteria for practice guideline development and evaluation. Am Psychol 2002, 5:1048-1051. American Psychological Association.
12. Humphreys K, Trafton JA, Oliva EM. Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment Study. J Subst Abuse Treat 2008, 34:173-179. 10.1016/j.jsat.2007.03.001, 17499955.
13. Kovas AE, McFarland BH, McCarty DJ, Boverman JF, Thayer JA. Buprenorphine for acute heroin detoxification: diffusion of research into practice. J Subst Abuse Treat 2007, 32:199-206. 10.1016/j.jsat.2006.08.003, 17306728.
14. Simpson DD. A conceptual framework for transferring research to practice. J Subst Abuse Treat 2002, 22:171-182. 10.1016/S0740-5472(02)00231-3, 12072162.
15. Thomas CP, Wallack SS, Lee S, McCarty D, Swift R. Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat 2003, 24:1-11. 10.1016/S0740-5472(02)00319-7, 12646325.
16. Rogers EM. Diffusion of Innovations 2003, New York, The Free Press, 4.
17. Rogers EM. Diffusion of Innovations 1995, New York, The Free Press, 4.
18. Gotham H. Diffusion of mental health and substance abuse treatments: Development, dissemination, and implementation. Clin Psychol 2004, 11:160-176.
19. Fixsen DL, Naoom SF, Blase KA, Friedman RM, Wallace F. Implementation Research: A Synthesis of the Literature 2005, Tampa, FL, University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network.
20. Forman RF, Bovasso G, Woody G. Staff beliefs about addiction treatment. J Subst Abuse Treat 2001, 21:1-9. 10.1016/S0740-5472(01)00173-8, 11516921.
21. Inouye J, Kristopatis R, Stone E, Pelter M, Sandhu M, Weingarten S. Physicians' changing attitudes toward guidelines. J Gen Intern Med 1998, 13:324-326. 10.1046/j.1525-1497.1998.00098.x, 1496951, 9613888.
22. Huag HA, Shopshire M, Tajima B, Gruber V, Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ 2008, 38:181-192. 10.2190/DE.38.2.f, 2742313, 18724657.
23. Knudsen HK, Ducharme LJ, Roman PM. Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphine. Am J Addict 2007, 16:365-371. 10.1080/10550490701525418, 17882607.
24. McCarty D, Levine H, Steenrod S, Prost C, Meredith T. New England Outpatient Study: Preliminary Findings 1998, Waltham, MA: Brandeis University.
25. McLellan AT, Cacciola J, Kushner H, Peters R, Smith I, Pettinati H. The fifth edition of the Addiction Severity Index: Historical critique and normative data. J Subst Abuse Treat 1992, 9:199-213. 10.1016/0740-5472(92)90062-S, 1334156.
26. Beck A, Steer R, Brown G. Manual for the Beck Depression Inventory 1996, San Antonio, TX, The Psychological Corporation, 2.
27. Steenrod S. The relationship between managed care and standardized clinical practices in outpatient substance abuse treatment programs in New England. Dissertation Abstracts International: Section B: The Sciences & Engineering 1999, 60(6-B):2594.
28. Bollen K. Structural Equations with Latent Variables 1989, New York: Wiley.
29. Hatcher L. A Step-By-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modeling 1994, Cary, NC, SAS Institute.
30. SAS SAS Version 8 1999, Cary, NC: SAS Institute Inc, SAS.
31. Marinelli-Casey P, Domier CP, Rawson RA. The gap between research and practice in substance abuse treatment. Psychatr Serv 2002, 53:984-987.
32. McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, opinions, and beliefs. Psychiatr Serv 2007, 58:181-190. 10.1176/appi.ps.58.2.181, 17287373.
33. Torrey WC, Drake RE, Dixon L, Burns BJ, Flynn L, Rush AJ, Clark RE, Klatzker D. Implementing evidence-based practices for persons with serious mental illness. Psychiatr Serv 2001, 52:45-50. 10.1176/appi.ps.52.1.45, 11141527.
34. Miller WR, Zweben J, Johnson WR. Evidence-based treatment: Why, what, where, when, and how?. J Subst Abuse Treat 2005, 29:267-276. 10.1016/j.jsat.2005.08.003, 16311179.
35. Knudsen H, Johnson J, Roman P. Retaining counseling staff at substance abuse treatment centers: Effects of management practices. J Subst Abuse Treat 2003, 24:129-135. 10.1016/S0740-5472(02)00357-4, 12745030.
36. Capoccia V, Abeles J. A question of leadership: In what ways has the challenge of improving health and health care informed your understanding and practice of leadership?. Leadership in Action 2006, 26:12-13.
37. Edmundson E, McCarty D. Implementing Evidence-Based Practices for Treatment of Alcohol and Drug Disorders 2006, New York, Haworth Press.
38. Kimberly J, Evanisko M. Organizational innovation: The influence of individual, organizational, and contextual factors on hospital adoption of technological and administrative innovations. Acad Manage J 1981, 24:689-713. 10.2307/256170, 10253688.